Norliqva Solution
NDC Package 46287-035-15

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Norliqva (amlodipine) solution is nORLIQVA is contraindicated in patients with sensitivity to amlodipine. This formulation utilizes a solution delivery system. Marketed by Cmp Pharma, Inc., this product is identified by NDC 46287-035 and is authorized under FDA application NDA214439.

Identification & Billing

NDC Package Code
46287-035-15
Package Description
150 mL in 1 BOTTLE
Product Code
46287-035
11-Digit Billing Format
46287003515
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
150 ML
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Norliqva
Non-Proprietary Name
Amlodipine
Substance Name
Amlodipine
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
AMLODIPINE 1 mg/mL
Pharmacologic Class
Usage Information
NORLIQVA is contraindicated in patients with sensitivity to amlodipine.

Regulatory & Marketing

Labeler Name
Cmp Pharma, Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA214439
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
04-15-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 46287-035-15 identifies a specific commercial package of 150 ml in 1 bottle of Norliqva, a human prescription drug labeled by Cmp Pharma, Inc.. This solution is formulated for oral use and contains amlodipine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cmp Pharma, Inc. on April 15, 2022. The current certification is valid through December 31, 2026.

How is this Cmp Pharma, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 46287003515. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 150 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
46287-035-15
11-Digit CMS (5-4-2)
46287-0035-15

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.